Structure and Function of MRINCT02236143
Ultrahigh Field Body MR Imaging
An observational study of Structure and Function of MRI, run by University of Minnesota at 1 site in United States.
Trial summary
The primary objective of this study is to develop new ways to acquire MRI data and/or new ways to analyze the acquired data. Read more about this study
- Who is it for?
- Ages 18 to 75 yearsHealthy volunteers can take part
- Conditions the study is for
- Structure and Function of MRI
- How many people
- 500 participants
- Where
- 1 siteUnited States
- Study dates
- 21 Feb 2013to 31 Jan 2029
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Healthy male or females over the age of 18, recruiting by invitation only.
Who may be able to join
- Healthy male or female volunteer over the age of 18
Who cannot join
- Exclusion criteria include those associated with the use of MR as the imaging modality. The specific set of exclusion criteria for a given study will depend on the specific study to be performed which will be made clear on initial contact and during consent. In addition, other medical conditions deemed by the PI or associates to make the patient ineligible for protocol procedures may also arise.
- Exclusion criteria will be assessed during a safety screening interview and during final consent. A questionnaire will be provided regarding general health and exclusion/inclusion criteria. The investigator doing the interview will determine if any of the exclusion criteria apply. Subjects will be asked:
- To describe any previous surgeries to help subjects and study staff open a dialogue as to any possible contraindications listed in the yes/no section below.
- If they are claustrophobic and to rate the severity.
- If they wear hearing aids and if they can be removed for the scan.
- If they have a transdermal delivery system, and if yes where is it located and if it can be removed for the study.
Show all 41Show fewer
- If they wear colored contact lenses and, if yes, can they be removed for the study.
- To provide a list of medications, dosages and time of last dose for medicines taken regularly.
- To identify if they have any pre-existing medical conditions including Hypertension, Hypotension, Diabetes, Cardiovascular Disease and Fever.
- To identify if they ever had an operation.
- To indicate if they have ever been injured by a metallic foreign body which was never removed.
- If they wear braces and/or if they have removable bridgework, false teeth or a permanent retainer.
- If they have any tattoos, non-removable body piercings or hair extensions.
- If they are currently using/wearing an IUD or diaphragm.
- If they have any reason to believe they are pregnant. (If the subjects are unsure about their pregnancy status, test kits will be available to subjects).
- In addition, a set of yes/no questions will be asked in the screening form for the patient to confirm or deny the presence of items that may be hazardous to their safety and/or some interfere with the MRI examination, including:
- No Cardiac pacemaker
- No Implanted cardiac defibrillator
- No Carotid artery vascular clamp
- No Intravascular stents, filters, or coils
- No Aortic clip
- No Internal pacing wires
- No Vascular access port and/or catheter
- No Swan-Ganz catheter
- No Shunt (spinal or intraventricular)
- No Aneurysm clip(s)
- No Neurostimulator
- No Electrodes (on body, head, or brain)
- No Heart valve prosthesis
- No Any type of prosthesis (eye, penile, etc.)
- No Artificial limb or joint replacement
- No Bone growth/fusion stimulator
- No Bone/joint pin, screw, nail, wire, plate
- No Metal rods in bones
- No Harrington rods (spine)
- No Metal or wire mesh implants
- No Wire sutures or surgical staples
- No Insulin pump or infusion device
- No Any metal fragments (i.e. metal shop)
- No Any implant held in place by a magnet
- No Cochlear, otologic, or ear implant
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site
University of Minnesota CMRR
Minneapolis, Minnesota, 55455
About this study
The primary objective of this study is to develop new ways to acquire MRI data and/or new ways to analyze the acquired data.
Read the detailed description
The acquired data will be used to investigate the structure and function of the body. In addition the developmental aspect of this study, certain information may be used to obtain normal values for healthy adult structural and functional information. This information would be valuable if and when the developed methods are incorporated into future clinical studies involving patient populations which would be recruited under separate protocols. Our hypotheses is that imaging and spectroscopy methods can be developed to a level where the increased sensitivity and resolution of 7 Tesla (7T) MRI will improve the non-invasive studies of the human body.
- Conditions
- Structure and Function of MRI
- Keywords
- Healthy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| MRI | Subjects undergoing MRI |
What is being measured
The primary outcome is the main question the study is designed to answer.
Structure and Function of MRI
Validate MRI measurement
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Sep 2014 (estimated)
- Study start21 Feb 2013
- Primary completion31 Jan 2029 (estimated)
- Study completion31 Jan 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Structure and Function of MRIStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 500 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Minnesota
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Greg Meztger, PhD, Principal investigator, University of Minnesota
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02236143
- Sponsor's protocol ID
- 1212M24883
- Status last verified
- Apr 2026
- First submitted
- 13 Mar 2013
- Last updated
- 20 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Ultrahigh Field Body MR Imaging
- ClinicalTrials.gov ID
- NCT02236143
- Acronym / sponsor ID
- 1212M24883
- Conditions
- Structure and Function of MRI
- Keywords
- Healthy
- Study type
- Observational
- Recruitment status
- Enrolling by invitation
- Enrolment
- 500 participants (estimated)
- Lead sponsor
- University of MinnesotaUniversity, hospital or other
- Study start
- 21 Feb 2013 (actual)
- Primary completion
- 31 Jan 2029 (estimated)
- Study completion
- 31 Jan 2029 (estimated)
- First posted
- 10 Sep 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The primary objective of this study is to develop new ways to acquire MRI data and/or new ways to analyze the acquired data.
Detailed description
The acquired data will be used to investigate the structure and function of the body. In addition the developmental aspect of this study, certain information may be used to obtain normal values for healthy adult structural and functional information. This information would be valuable if and when the developed methods are incorporated into future clinical studies involving patient populations which would be recruited under separate protocols. Our hypotheses is that imaging and spectroscopy methods can be developed to a level where the increased sensitivity and resolution of 7 Tesla (7T) MRI will improve the non-invasive studies of the human body.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| MRI | – | –Subjects undergoing MRI |
Who may qualify
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Healthy male or females over the age of 18, recruiting by invitation only.
Key inclusion criteria (1 listed)
- Healthy male or female volunteer over the age of 18
Key exclusion criteria (41 listed)
- Exclusion criteria include those associated with the use of MR as the imaging modality. The specific set of exclusion criteria for a given study will depend on the specific study to be performed which will be made clear on initial contact and during consent. In addition, other medical conditions deemed by the PI or associates to make the patient ineligible for protocol procedures may also arise.
- Exclusion criteria will be assessed during a safety screening interview and during final consent. A questionnaire will be provided regarding general health and exclusion/inclusion criteria. The investigator doing the interview will determine if any of the exclusion criteria apply. Subjects will be asked:
- In addition, a set of yes/no questions will be asked in the screening form for the patient to confirm or deny the presence of items that may be hazardous to their safety and/or some interfere with the MRI examination, including:
- No Cardiac pacemaker
- No Implanted cardiac defibrillator
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Structure and Function of MRI
Time frame: Baseline
Validate MRI measurement
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Apr 2026.
Related trials for Structure and Function of MRI
RecruitingObservational study
Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders
Mood Disorders, Anxiety Disorders
Active, not recruitingObservational study
Brain Functional MRI in Older Women With Breast Cancer (Brain fMRI-BC)
Breast Cancer
Not yet recruitingPhase 4
Mechanistic Evaluation of Atrasentan in Patients With IgA Nephropathy (IgAN)
IgA Nephropathy (IgAN), Immunoglobulin A Nephropathy (IgAN)
Recruiting
Structure and Function MRI of Asthma
Asthma
RecruitingPhase 4
Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis
Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM), Amyloidosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Greg Meztger, PhD principal investigator
University of Minnesota
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Structure and Function of MRI, run by University of Minnesota at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 41 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 20 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Structure and Function of MRI (time frame: Baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Apr 2026.